Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced ...
Proteomics International says its PromarkerD diabetes test reshapes medical decision-making, with high scores prompting an ...
In a phase III trial, pre-op MRI did not reduce locoregional recurrences or improve survival among women with early-stage ...
Insecticide-treated nets (ITNs) are the most impactful and cost-effective control tool against malaria. ITNs are primarily distributed through triennial mass campaigns across Africa, though overall ...
Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures and ...
Dyadic Applied BioSolutions ('Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, ...
The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...
RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in ...
GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced that the GUARDIAN (Genomic Uniform-screening Against Rare Disease In All Newborns) study has been ...
The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
EDITORIAL: A detailed clarification issued by the Ministry of Finance (MoF) on International Monetary Fund’s (IMF’s) new ...
The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback